Project Funding

Written by Rare Disease Communities Team, published 6 months ago.

Funding for the Rare Disease Communities project comes from several types of sources such as patient organisations (AFM), public funds (EAHC), corporate syndicates (LEEM) and pharmaceutical companies. All funding supports the project as a whole and plays an essential part in launching and sustaining all participating rare disease communities.

AFM (French Association for Neuromuscular Disorders)
LEEM (Les Entreprises du medicament)

European Commission DG Health and Consumers
Alexion Pharmaceuticals
Celgene Corporation

CSL Behring

Medtronic Foundation


The material only reflects the views of the author, and funders cannot be held responsible for any use which may be made of the information contained herein.

Written by Rare Disease Communities Team, published 6 months ago.

No comment for «Project Funding»

Expand all ]

No comment yet.

Leave a comment

You must be registered and signed in to leave a comment. Sign in now.